| Literature DB >> 12930393 |
Philippe Guardiola1, Peter Kurre, Amalia Vlad, Jean-Michel Cayuela, Hélène Espérou, Agnès Devergie, Patricia Ribaud, Gérard Socié, Patrice Richard, Richard Traineau, Rainer Storb, Eliane Gluckman.
Abstract
Allogeneic transplantation is the only curative treatment for Fanconi anaemia (FA) patients who develop myeloid malignancies. Dose-intensive preparative regimens, to decrease disease recurrence, lead to unacceptable transplant-related toxicity in FA. We report the outcome of three FA patients with such malignancies who underwent transplantation with reduced-intensity preparative regimens. This approach was well tolerated, even as second transplantations, and resulted in complete leukaemic remissions. However, the graft-versus-leukaemia effect was associated with fatal graft-versus-host disease. Even after transplantation, myeloid malignancies remain associated with a poor outcome in FA, and this argues in favour of early intervention when suitable donors are available.Entities:
Mesh:
Year: 2003 PMID: 12930393 DOI: 10.1046/j.1365-2141.2003.04503.x
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998